Objective To investigate the value of Codman Hakim pressure adjustable shunt in the treatment of hydrocephalus associated with congenital intracranial anomalous venous return. Methods 2 patients whose diagnosis were c...Objective To investigate the value of Codman Hakim pressure adjustable shunt in the treatment of hydrocephalus associated with congenital intracranial anomalous venous return. Methods 2 patients whose diagnosis were confirmed by CT,MRI,MRV and DSA and programmable ventriculoperitoneal shunting was given.展开更多
Background: Portal biliopathy producing intrahepa- tic and extrahepatic biliary ductai abnormalities from portal hypertension, particularly with extrahepatic portal vein obstruction (EHPVO) is common. A majority of th...Background: Portal biliopathy producing intrahepa- tic and extrahepatic biliary ductai abnormalities from portal hypertension, particularly with extrahepatic portal vein obstruction (EHPVO) is common. A majority of these patients are asymptomatic, but oc- casionally there is symptomatic biliary obstruction, and cholangitis and choledocholithiasis. Objective: To explore the principles of diagnosis and treatment of portal biliopathy. Data sources: To review the literature of portal bili- opathy. Conclusions: Endoscopic sphincterotomy, stone ex- traction and supportive drainage could effectively re- lieve cholangitis when jaundice is associated with common bile duct stones. Definitive decompressive portal-system vein shunting operation and choledo- cho-jejunostomy are sometimes required when biliary obstruction is recurrent and progressive.展开更多
Portal hypertension is a group of syndrome characterized by splenic hyperfunction, esophageal and gastric varices and ascites caused by abnormal portal vein hemodynamics. Among them, upper gastrointestinal bleeding ca...Portal hypertension is a group of syndrome characterized by splenic hyperfunction, esophageal and gastric varices and ascites caused by abnormal portal vein hemodynamics. Among them, upper gastrointestinal bleeding caused by esophageal and gastric varices is the most dangerous complication, which often threatens the lives of patients. After half a century of development, the treatment of portal hypertension is divided into two categories: medical drug therapy, endoscopic therapy and surgical treatment. With the understanding of portal hypertension and the continuous development of medical technology, the surgical operation of portal hypertension has also been greatly improved, reducing postoperative complications and improving the quality of life of patients after operation. However, at present, there is no surgical method that can completely cure portal hypertension. This article reviews the progress of surgical treatment of portal hypertension in recent years, in order to provide reference for the surgical treatment of portal hypertension.展开更多
文摘Objective To investigate the value of Codman Hakim pressure adjustable shunt in the treatment of hydrocephalus associated with congenital intracranial anomalous venous return. Methods 2 patients whose diagnosis were confirmed by CT,MRI,MRV and DSA and programmable ventriculoperitoneal shunting was given.
文摘Background: Portal biliopathy producing intrahepa- tic and extrahepatic biliary ductai abnormalities from portal hypertension, particularly with extrahepatic portal vein obstruction (EHPVO) is common. A majority of these patients are asymptomatic, but oc- casionally there is symptomatic biliary obstruction, and cholangitis and choledocholithiasis. Objective: To explore the principles of diagnosis and treatment of portal biliopathy. Data sources: To review the literature of portal bili- opathy. Conclusions: Endoscopic sphincterotomy, stone ex- traction and supportive drainage could effectively re- lieve cholangitis when jaundice is associated with common bile duct stones. Definitive decompressive portal-system vein shunting operation and choledo- cho-jejunostomy are sometimes required when biliary obstruction is recurrent and progressive.
文摘Portal hypertension is a group of syndrome characterized by splenic hyperfunction, esophageal and gastric varices and ascites caused by abnormal portal vein hemodynamics. Among them, upper gastrointestinal bleeding caused by esophageal and gastric varices is the most dangerous complication, which often threatens the lives of patients. After half a century of development, the treatment of portal hypertension is divided into two categories: medical drug therapy, endoscopic therapy and surgical treatment. With the understanding of portal hypertension and the continuous development of medical technology, the surgical operation of portal hypertension has also been greatly improved, reducing postoperative complications and improving the quality of life of patients after operation. However, at present, there is no surgical method that can completely cure portal hypertension. This article reviews the progress of surgical treatment of portal hypertension in recent years, in order to provide reference for the surgical treatment of portal hypertension.
文摘目的评估内镜序贯经颈静脉肝内门体分流术(TIPS)治疗肝硬化急性食管胃静脉曲张破裂出血(EGVB)的安全性及有效性。方法将2019年9月—2021年3月接受内镜序贯TIPS治疗的肝硬化急性EGVB 31例作为内镜序贯TIPS组,将接受单纯内镜序贯治疗的46例作为内镜序贯组。观察内镜序贯TIPS组门静脉压力梯度变化情况,比较2组静脉曲张改善程度及肝功能变化,术后1、3、6、12个月再出血率及肝性脑病发生率,随访结束后分析2组生存情况。结果内镜序贯TIPS组术后门静脉压力梯度低于术前(P<0.01)。内镜序贯TIPS组术后丙氨酸转氨酶(ALT)、天冬氨酸转氨酶(AST)术后1个月高于其他时点(P<0.05),术后3个月开始下降;内镜序贯TIPS组术后血清胆红素升高,术后3个月直接胆红素(DBIL)和间接胆红素(IBIL)升至高峰,术后6个月逐渐下降(P<0.05)。内镜序贯组术后3、7 d ALT、AST较术前降低,ALB较术前升高(P<0.05);术后1个月总胆红素(TBIL)水平低于术前(P<0.05);术后7 d及术后1、3个月DBIL低于术前(P<0.05)。2组术后静脉曲张根除率比较差异无统计学意义(P>0.05)。内镜序贯TIPS组术后6、12个月再出血率低于内镜序贯组(P<0.01);2组术后肝性脑病发生率及术后1年生存率比较差异均无统计学意义(P>0.05)。结论TIPS可降低门静脉压力,静脉曲张根除率与内镜序贯治疗相当,但可有效降低再出血率,而并不降低生存率且不增加肝性脑病发生率。内镜序贯TIPS治疗肝硬化EVGB安全有效。
